#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epidermolysis bullosa Guillain-Barre syndrome Cystic fibrosis respiratory infection suppression Subarachnoid haemorrhage Neuroendocrine cell hyperplasia of infancy Epileptic encephalopathy Small cell lung cancer Craniocerebral injury Hereditary angioedema with C1 esterase inhibitor deficiency Cardiomyopathy Scedosporium infection Congenital megacolon Pulmonary hypertension Ocular myasthenia Oesophageal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Basic Information Gastrointestinal stromal tumour – Trials in Disease Angiosarcoma recurrent – Basic Information Mast cell activation syndrome Adrenogenital syndrome – Life with Disease Myxofibrosarcoma Acquired haemophilia – Trials in Disease Ewing’s sarcoma metastatic – Life with Disease Andersen-Tawil syndrome – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Loperamide Hydrochloride Phenylephrine SELTOREXANT Gtaexs617 FIBRIN Argon Sultiame Crn04894 MARALIXIBAT Gemlapodect Levodopa Emiplacel Stx-241 Paltusotine Alnuctamab ZUNIBERGENE ROCPARVOVEC Tin816 FOSMANOGEPIX Irinotecan Serpina1(Human)-Aav8-1 More therapies…

    Learn about Your Condition

    Epicondylitis Skin candida Malignant oligodendroglioma Depression Procedural hypotension Uterine leiomyoma Triple positive breast cancer Rectal cancer stage III Mite allergy Brain stem glioma Dedifferentiated liposarcoma Haemophilia Adenocarcinoma pancreas Binge eating Haemolytic uraemic syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of botulinum toxin type A versus placebo to treat bowel movement problems in patients recovering from surgery for rectal cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium

  • Study evaluating the effect of levetiracetam on recovery in patients with intracerebral haemorrhage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Levetiracetam
    France

  • A study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Vestibular disorder
    Investigated Drugs:
    • Levothyroxine Sodium
    • Placebo
    Germany

  • A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Levetiracetam
    • Methotrexate
    • Blinatumomab
    Belgium France Germany Italy The Netherlands Romania +1

  • Using a drug combination to treat vaginal flora abnormalities in pregnant women at high risk of preterm birth.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial vaginosis
    Investigated Drugs:
    • Azithromycin Dihydrate
    • Clotrimazole
    • Ceftriaxone
    France

  • A study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Regn7508
    • Acetylsalicylic Acid
    Greece Italy Spain
Previous Page
1 … 728 729 730 731 732 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!